Trial Identifier: | D9350C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05647122 |
Start Date: | December 2022 |
Primary Completion Date: | October 2025 |
Study Completion Date: | October 2025 |
Condition: | Cancer - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
AU | Melbourne, AU, 3000 |
CN | Guangzhou, CN, 510100 |
ES | Barcelona, ES, 8035 |
ES | Madrid, ES, 28040 |
ES | Sevilla, ES, 41013 |
JP | Chuo-ku, JP, 104-0045 |
JP | Kashiwa, JP, 277-8577 |
US, CA | Duarte, CA, US, 91010 |
US, CA | Irvine, CA, US, 92618 |
US, IL | Chicago, IL, US, 60637 |
US, NY | Mineola, NY, US, 11501 |
US, NY | New York, NY, US, 10021 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, NY | New York, NY, US, 10016 |
US, PA | Philadelphia, PA, US, 19104 |
US, RI | Providence, RI, US, 02903 |
US, TX | Houston, TX, US, 77030 |
US, VA | Fairfax, VA, US, 22031 |